This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Labbé, E. Articles by Attisano, L. Search for Related Content PubMed PubMed Citation Articles by Labbé, E. Articles by Attisano, L.

Transcriptional Cooperation between the Transforming Growth Factor-ß and Wnt Pathways in Mammary and Intestinal Tumorigenesis

Departments of ¹ Medical Biophysics and ² Biochemistry, University of Toronto; ³ Department of Surgery, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; and ⁴ Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

Requests for reprints: Liliana Attisano, Department of Biochemistry, Terrence Donnelly Centre for Cellular and Biomolecular Research, Room 1008, 160 College Street, University of Toronto, Toronto, ON, Canada M5S 3E1. Phone: 416-946-3129; Fax: 416-978-8548; E-mail: liliana.attisano{at}utoronto.ca.

Transforming growth factor-ß (TGF-ß) and Wnt ligands function in numerous developmental processes, and alterations of both signaling pathways are associated with common pathologic conditions, including cancer. To obtain insight into the extent of interdependence of the two signaling cascades in regulating biological responses, we used an oligonucleotide microarray approach to identify Wnt and TGF-ß target genes using normal murine mammary gland epithelial cells as a model. Combination treatment of TGF-ß and Wnt revealed a novel transcriptional program that could not have been predicted from single ligand treatments and included a cohort of genes that were cooperatively induced by both pathways. These included both novel and known components or modulators of TGF-ß and Wnt pathways, suggesting that mutual feedback is a feature of the coordinated activities of the ligands. The majority of the cooperative targets display increased expression in tumors derived from either Min (many intestinal neoplasia) or mouse mammary tumor virus (MMTV)–Wnt1 mice, two models of Wnt-induced tumors, with nine of these genes (Ankrd1, Ccnd1, Ctgf, Gpc1, Hs6st2, IL11, Inhba, Mmp14, and Robo1) showing increases in both. Reduction of TGF-ß signaling by expression of a dominant-negative TGF-ß type II receptor in bigenic MMTV-Wnt1/DNIIR mice increased mammary tumor latency and was correlated with a decrease in expression of Gpc1, Inhba, and Robo1, three of the TGF-ß/Wnt cooperative targets. Our results indicate that the TGF-ß and Wnt/ß-catenin pathways are firmly intertwined and generate a unique gene expression pattern that can contribute to tumor progression. [Cancer Res 2007;67(1):75–84]

This article has been cited by other articles:

				A. M. Viloria-Petit, L. David, J. Y. Jia, T. Erdemir, A. L. Bane, D. Pinnaduwage, L. Roncari, M. Narimatsu, R. Bose, J. Moffat, et al. A role for the TGF{beta}-Par6 polarity pathway in breast cancer progression PNAS, August 18, 2009; 106(33): 14028 - 14033. [Abstract] [Full Text] [PDF]

				C. Dasgupta, R. Sakurai, Y. Wang, P. Guo, N. Ambalavanan, J. S. Torday, and V. K. Rehan Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1031 - L1041. [Abstract] [Full Text] [PDF]

				L. L. Scurr, A. D. Guminski, Y.-E. Chiew, R. L. Balleine, R. Sharma, Y. Lei, K. Pryor, G. V. Wain, A. Brand, K. Byth, et al. Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer Clin. Cancer Res., November 1, 2008; 14(21): 6924 - 6932. [Abstract] [Full Text] [PDF]

				N. L. Cho, M. Redston, A. G. Zauber, A. M. Carothers, J. Hornick, A. Wilton, S. Sontag, N. Nishioka, F. M. Giardiello, J. R. Saltzman, et al. Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial Cancer Prevention Research, June 1, 2008; 1(1): 21 - 31. [Abstract] [Full Text] [PDF]

				X. Guo, A. Ramirez, D. S. Waddell, Z. Li, X. Liu, and X.-F. Wang Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling Genes & Dev., January 1, 2008; 22(1): 106 - 120. [Abstract] [Full Text] [PDF]